Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety and Efficacy Study of Switching From Epzicom to Truvada

ClinicalTrials.gov ID: NCT00724711

Public ClinicalTrials.gov record NCT00724711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Open Label Phase IV Study to Evaluate the Rationale of Switching From Fixed Dose Abacavir (ABC)/Lamivudine (3TC) to Fixed Dose Tenofovir DF (TDF)/Emtricitabine (FTC) in Virologically Suppressed, HIV-1 Infected Patients Maintained on a Ritonavir Boosted Protease Inhibitor Containing Antiretroviral Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This protocol describes a prospective, randomized, open-label, multicenter study to evaluate the safety and efficacy of switching from fixed dose abacavir (ABC)/lamivudine (3TC) to fixed dose emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) in virologically suppressed, human immunodeficiency virus type 1 (HIV-1) infected subjects maintained on a ritonavir-boosted protease inhibitor (PI/r)-containing antiretroviral (ARV) regimen. Duration of treatment is 48 weeks.

Study identification

NCT ID
NCT00724711
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Gilead Sciences
Industry
Enrollment
312 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2008 (Type not available)
Primary completion
Mar 2011 (Actual)
Completion
Apr 2011 (Actual)
Last update posted
May 28, 2012

2008 – 2011

United States locations

U.S. sites
73
U.S. states
19
U.S. cities
50
Facility City State ZIP Site status
Health For Life Clinic, PLLC Little Rock Arkansas 72207 —
Vista Medical Partners Beverly Hills California 90210 —
AHF Beverly Hills California 90211 —
Pacific Oaks Medical Group Beverly Hills California 90211 —
Center for Special Immunology Fountain Valley California 92708 —
Living Hope Clinical Foundation Long Beach California 90813 —
Jeffrey Goodman Special Care Clinic Los Angeles California 90028 —
Peter J. Ruane, MD, Inc. Los Angeles California 90036 —
Anthony M Mills, MD Los Angeles California 90069 —
Orange Coast Medical Group Newport Beach California 92663 —
Tarzana Treatment Center Northridge California 91324 —
Alameda County Medical Center Oakland California 94602 —
Health Management Institute, Inc. San Francisco California 94114 —
Metropolis Medical San Francisco California 94115 —
Kaiser Permanente Denver Colorado 80205 —
Blick Medical Associates Norwalk Connecticut 06851 —
Biogenomx Research Institute, LLC Fort Lauderdale Florida 33306 —
Life Way Inc. Fort Lauderdale Florida 33308 —
Therafirst Medical Centers Fort Lauderdale Florida 33308 —
HIV Clinical Research Fort Lauderdale Florida 33311 —
Gary Richmond, MD, PA, Inc. Fort Lauderdale Florida 33316 —
University of Florida Jacksonville Florida 32206 —
The Kinder Medical Group Miami Florida 33133 —
University of Miami Miami Florida 33136 —
South Florida Infectious Diseases and Tropical Medicine Center Miami Florida 33176 —
Community Health of South Florida Inc. Miami Florida 33190 —
Wohlfeiler, Piperato and Associates, LLC Miami Beach Florida 33139 —
Orlando Immunology Center Orlando Florida 32803 —
Infectious Diseases Associates of NW FL Pensacola Florida 32504 —
Associates in Infectious Diseases Port Saint Lucie Florida 34952 —
Barry M. Rodwick, M.D. Safety Harbor Florida 34695 —
USF Health Tampa Florida 33602 —
Infectious Disease Research Institute, Inc. Tampa Florida 33614 —
Clinical Pharmacology Services Tampa Florida 33617 —
Atlanta Infectious Disease Group, PC Atlanta Georgia 30309 —
Infectious Disease Solutions Atlanta Georgia 30309 —
Family Healthcare of Atlanta PC Atlanta Georgia 30318 —
Chatham County Health Department Savannah Georgia 31401 —
Howard Brown Health Center Chicago Illinois 60613 —
NorthStar Medical Center Chicago Illinois 60657 —
University of Louisville Louisville Kentucky 40202 —
Chase Brexton Health Services Baltimore Maryland 21201 —
MetroWest Medical Center Framingham Massachusetts 01702 —
Community Research Initiative of New England - WEST Springfield Massachusetts 01107 —
The Research Institute Springfield Massachusetts 01107 —
Be Well Medical Center Berkley Michigan 48072 —
Henry Ford Hospital Detroit Michigan 48202 —
Michigan State University, College of Osteopathic Medicine East Lansing Michigan 48824 —
St. John Hospital Internal Medicine Clinic - Mack Office Building Grosse Point Woods Michigan 48236 —
Hennepin County Medical Center Minneapolis Minnesota 55145 —
Abbott Northwestern Hospital Minneapolis Minnesota 55404 —
ID Associates, PA Hillsborough New Jersey 08844 —
Saint Michael's Medical Center Newark New Jersey 07102 —
South Jersey Infectious Disease Somers Point New Jersey 08244 —
Upstate Infectious Diseases Associates Albany New York 23309 —
Greiger Clinic Mount Vernon New York 10550 —
Ricky K. Hsu, MD, PC New York New York 10011 —
AIDS Community Health Center Rochester New York 14604 —
University of Rochester Medical Center Rochester New York 14642 —
ID Consultants, P.A. Charlotte North Carolina 28209 —
East Carolina University The Brody School of Medicine Greenville North Carolina 27858 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27157 —
Summa Health System Care Center Akron Ohio 44394 —
Central Texas Clinical Research Austin Texas 78705 —
Baylor University Medical Center Dallas Texas 75204 —
UT Southwestern Medical Center at Dallas Dallas Texas 75235 —
North Texas Inf. Disease Consultants Dallas Texas 75246 —
Tarrant County Infectious Disease Associates Fort Worth Texas 76104 —
Valley AIDS Counsel Harlingen Texas 78550 —
Therapeutic Concepts, PA Houston Texas 77004 —
Gordon E. Crofoot, MD, PA Houston Texas 77098 —
Daniel Coulston, MD Spokane Washington 99204 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00724711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2012 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00724711 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →